Krka, d. d. (LJSE: KRKG)

Market Cap	4.80B
Revenue (ttm)	1.90B
Net Income (ttm)	359.83M
Shares Out	30.75M
EPS (ttm)	11.67
PE Ratio	13.37
Forward PE	13.84
Dividend	7.50 (4.82%)
Ex-Dividend Date	Jul 23, 2024

Volume	4,344
Average Volume	6,867
Open	156.00
Previous Close	155.50
Day's Range	155.50 - 157.00
52-Week Range	114.50 - 159.00
Beta	0.51
RSI	75.00
Earnings Date	Jan 30, 2025

About Krka, d. d.

Krka, d. d. develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. Its prescription pharmaceuticals include medicines for cardiovascular, central nervous system, gastrointestinal tract, pain relief, diabetes, blood and blood-forming organs, anti-infectives for systemic use, oncology, and other applications. The company also provides non-prescription products, such as cough and cold pr...

• Industry: Pharmaceutical Preparations
• Founded: 1954
• Employees: 10,284
• Stock Exchange: Ljubljana Stock Exchange
• Ticker Symbol: KRKG

Financial Performance

In 2023, Krka, d. d.'s revenue was 1.81 billion, an increase of 5.18% compared to the previous year's 1.72 billion. Earnings were 313.95 million, a decrease of -13.58%.